Similar articles for PMID: 11241556

Year	Number of Results
1996	4
1998	7
1999	8
2000	14
2001	10
2002	17
2003	13
2004	7
2005	6
2006	6
2007	6
2008	8
2009	4
2010	7
2011	4
2012	3
2013	2
2014	4
2015	4
2016	1
2018	1
2019	2
2020	2
2021	1
2022	2
2023	2
2024	0

1

Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells.

Moretti RM, Marelli MM, Motta M, Polizzi D, Monestiroli S, Pratesi G, Limonta P. Moretti RM, et al. Prostate. 2001 Mar 1;46(4):327-35. doi: 10.1002/1097-0045(20010301)46:4<327::aid-pros1040>3.0.co;2-6. Prostate. 2001. PMID: 11241556 Free article.

2

Oncostatic activity of a thiazolidinedione derivative on human androgen-dependent prostate cancer cells.

Moretti RM, Montagnani Marelli M, Motta M, Limonta P. Moretti RM, et al. Int J Cancer. 2001 Jun 1;92(5):733-7. doi: 10.1002/1097-0215(20010601)92:5<733::aid-ijc1254>3.0.co;2-l. Int J Cancer. 2001. PMID: 11340580 Free article.

3

Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase.

Moretti RM, Montagnani Marelli M, Sala A, Motta M, Limonta P. Moretti RM, et al. Int J Cancer. 2004 Oct 20;112(1):87-93. doi: 10.1002/ijc.20387. Int J Cancer. 2004. PMID: 15305379 Free article.

4

Role of the orphan nuclear receptor ROR alpha in the control of the metastatic behavior of androgen-independent prostate cancer cells.

Moretti RM, Montagnani Marelli M, Motta M, Limonta P. Moretti RM, et al. Oncol Rep. 2002 Sep-Oct;9(5):1139-43. Oncol Rep. 2002. PMID: 12168086

5

RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.

Kumagai T, Ikezoe T, Gui D, O'Kelly J, Tong XJ, Cohen FJ, Said JW, Koeffler HP. Kumagai T, et al. Clin Cancer Res. 2004 Feb 15;10(4):1508-20. doi: 10.1158/1078-0432.ccr-0476-03. Clin Cancer Res. 2004. PMID: 14977855

6

Involvement of the mt1 melatonin receptor in human breast cancer.

Ram PT, Dai J, Yuan L, Dong C, Kiefer TL, Lai L, Hill SM. Ram PT, et al. Cancer Lett. 2002 May 28;179(2):141-50. doi: 10.1016/s0304-3835(01)00873-4. Cancer Lett. 2002. PMID: 11888668

7

Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells.

Marelli MM, Limonta P, Maggi R, Motta M, Moretti RM. Marelli MM, et al. Prostate. 2000 Nov 1;45(3):238-44. doi: 10.1002/1097-0045(20001101)45:3<238::aid-pros6>3.0.co;2-w. Prostate. 2000. PMID: 11074526 Free article.

8

Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.

Hashimoto K, Ethridge RT, Evers BM. Hashimoto K, et al. Int J Gastrointest Cancer. 2002;32(1):7-22. doi: 10.1385/IJGC:32:1:7. Int J Gastrointest Cancer. 2002. PMID: 12630765

9

Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells.

Shen JC, Klein RD, Wei Q, Guan Y, Contois JH, Wang TT, Chang S, Hursting SD. Shen JC, et al. Mol Carcinog. 2000 Oct;29(2):92-102. doi: 10.1002/1098-2744(200010)29:2<92::aid-mc6>3.0.co;2-q. Mol Carcinog. 2000. PMID: 11074606

10

20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.

Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP. Koike M, et al. Anticancer Res. 1999 May-Jun;19(3A):1689-97. Anticancer Res. 1999. PMID: 10470102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

136 results

Results by year